Immunohistochemical staining revealed that the expression of α-SMA significantly increased in the interstitium of the lung, peribronchial, and perivascular tissue of the COPD group in comparison with the Sham group, and the effect was suppressed by ginsenoside Rg1 administration (Figure 2(b)). Here, ACTA1 is linked to chronic obstructive pulmonary disease.